-
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureMcMurray JJ, Krum H, ATMOSPHERE Committees Investigators. -
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsBilchick KC, Wang Y, Cheng A et al.
-
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunctionGoldberg LR, Jessup M.
-
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart AssociationKonstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia.
-
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist SystemsBerg DD, Vaduganathan M, Stewart GC et al.
-
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced TrialSD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al.
-
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID TrialW Zareba, JP Daubert, CA Beck et al.
-
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureCK Nagaraju, EL Robinson, KR Sipido et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
